UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

The CARES Act requires the Government Accountability Office (GAO) to look at the government’s response to the COVID-19 pandemic, including vaccine development. The government watchdog has found that, ...

HONG KONG, Jan. 15, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...

Verndari is one of four companies selected by BARDA to develop alternative vaccine delivery technologies for existing and emerging infectious diseases. Verndari’s VaxiPatch™ technology shows ...

Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...